共 50 条
- [24] Safety of Palivizumab in Preterm Infants 29 to 32 Weeks' Gestational Age Without Chronic Lung Disease to Prevent Serious Respiratory Syncytial Virus Infection European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 414 - 417
- [30] Clinical characteristics and risk factors of severe respiratory syncytial virus-associated acute lower respiratory tract infections in hospitalized infants World Journal of Pediatrics, 2014, 10 : 360 - 364